Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$15,103,087
-$3,037,049 QoQ
Shares Held
59,468
-19.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#880
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Linscomb Wealth, Inc. holds $62,600,297 across 7 Drug Manufacturers - General names. JNJ ranks #2 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,722 | $17,796,484 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
59,468 | $15,103,087 | |
| 3 | MRK |
Merck & Co., Inc.
|
92,395 | $11,872,757 | |
| 4 | AMGN |
Amgen Inc
|
29,620 | $10,725,994 | |
| 5 | PFE |
Pfizer Inc
|
209,174 | $5,036,909 | |
| 6 | LLY |
ELI LILLY & Co
|
1,056 | $1,266,598 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,320 | $798,468 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,103,087 | 59,468 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $18,140,136 | 74,211 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $16,065,528 | 77,630 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $14,202,430 | 76,596 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $11,547,747 | 75,599 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $12,073,317 | 72,801 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $10,099,103 | 69,832 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $11,183,922 | 69,011 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $10,183,698 | 69,675 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,907,991 | 68,955 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,995,937 | 70,154 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $11,026,321 | 70,795 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $12,195,348 | 73,679 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $11,752,565 | 75,823 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $15,895,143 | 89,981 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,541,964 | 76,775 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $13,497,505 | 76,038 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,514,359 | 87,538 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $14,863,930 | 86,888 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $13,781,602 | 85,335 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $14,164,509 | 85,981 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $13,727,333 | 83,525 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $12,857,631 | 81,698 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $11,988,562 | 80,525 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,162,506 | 79,375 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $9,461,685 | 72,155 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||